Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Fox

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Sexually Transmitted Diseases|August 12, 2016
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus InfectionLinda Oseso, Amalia S Magaret, Keith R Jerome, et al.
Antiviral Therapy|January 7, 2016
Cerebrospinal fluid viral escape and acute encephalitis in a patient on boosted protease inhibitor monotherapyJuan Tiraboschi, Lisa Hamzah, Ata Siddiqui, et al.
HIV Medicine|February 23, 2022
Response to 'The use of tenofovir in patients with COVID-19'Ming Jie Lee, Achyuta Nori, Sarah Fidler, et al.
PLOS Global Public Health|September 18, 2025
Sexual risk and HIV prevention choices among men who are mobile for work: Results from a rapid ethnographic assessment for the Mobile Men trial in South Africa and UgandaThabang Manyaapelo, Martin Mbonye, Seluleko E Ngcobo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2025
Brief Report: Cystatin C Provides Substantially Higher Glomerular Filtration Rate Estimates Than Creatinine in a Subset of Black People With HIV on Current Antiretroviral RegimensLourdes Dominguez-Dominguez, Lisa Hamzah, Julie Fox, et al.
AIDS (London, England)|July 17, 2010
Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UKJulie Fox, Hannah Castro, Steve Kaye, et al.
AIDS (London, England)|March 3, 2006
Comparative potency of three antiretroviral therapy regimes in primary HIV infectionSarah Fidler, Christophe Fraser, Julie Fox, et al.
AIDS (London, England)|August 31, 2011
Could we, should we? YesJulie Fox, Peter J White, Jonathan Weber, et al.
Journal of the International AIDS Society|November 15, 2014
Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapyOlubanke Davies, Hannah Alexander, Nicola Robinson, et al.
International Journal of STD & AIDS|January 14, 2017
Impact of rectal gonorrhoea and chlamydia on HIV viral load in the rectum: potential significance for onward transmissionOlubanke Davies, Sinead Costelloe, Gemma Cross, et al.
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Sexually Transmitted Diseases|August 12, 2016
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus InfectionLinda Oseso, Amalia S Magaret, Keith R Jerome, et al.
Antiviral Therapy|January 7, 2016
Cerebrospinal fluid viral escape and acute encephalitis in a patient on boosted protease inhibitor monotherapyJuan Tiraboschi, Lisa Hamzah, Ata Siddiqui, et al.
HIV Medicine|February 23, 2022
Response to 'The use of tenofovir in patients with COVID-19'Ming Jie Lee, Achyuta Nori, Sarah Fidler, et al.
PLOS Global Public Health|September 18, 2025
Sexual risk and HIV prevention choices among men who are mobile for work: Results from a rapid ethnographic assessment for the Mobile Men trial in South Africa and UgandaThabang Manyaapelo, Martin Mbonye, Seluleko E Ngcobo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2025
Brief Report: Cystatin C Provides Substantially Higher Glomerular Filtration Rate Estimates Than Creatinine in a Subset of Black People With HIV on Current Antiretroviral RegimensLourdes Dominguez-Dominguez, Lisa Hamzah, Julie Fox, et al.
AIDS (London, England)|July 17, 2010
Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UKJulie Fox, Hannah Castro, Steve Kaye, et al.
AIDS (London, England)|March 3, 2006
Comparative potency of three antiretroviral therapy regimes in primary HIV infectionSarah Fidler, Christophe Fraser, Julie Fox, et al.
AIDS (London, England)|August 31, 2011
Could we, should we? YesJulie Fox, Peter J White, Jonathan Weber, et al.
Journal of the International AIDS Society|November 15, 2014
Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapyOlubanke Davies, Hannah Alexander, Nicola Robinson, et al.
International Journal of STD & AIDS|January 14, 2017
Impact of rectal gonorrhoea and chlamydia on HIV viral load in the rectum: potential significance for onward transmissionOlubanke Davies, Sinead Costelloe, Gemma Cross, et al.
Pageof 19